TY - Jour A2 - Pisani，Antonio Au - 湿摩尔，John B. Au - Arbelo，JoséAtíasAu - Catalán，MaríaJoséAu - Valldeora，Francesc Au - Rodriguez-Blazquez，Carmen Au - Martinez-Martin，Pablo Py - 2019 Da- 2019/03/28 TI - Psychometric Properties of the Apathy Scale in Advanced Parkinson’s Disease SP - 1965394 VL - 2019 AB - 目标。评估晚期帕金森病（APD）患者冷漠量表（AS-）西班牙语的心理学属性。 材料和方法。超过6个月，61名患者参加了左旋多巴肠肠凝胶（LCIG）的临床研究，并使用AS和其他临床工具评估。评估各种心理测量属性。 结果。患者（60.7％）均为68.02±7.43岁，距PD诊断12.57±5.97岁。“在”状态“中的中位HY为2（范围，1-4），平均左旋多巴当量日剂量为1455.98±456.00毫克。总体而言，可行性/可接受性的参数令人满意，除了作为物品的中等程度的楼层效果，但不得总分（均为3.3％）。Cronbach的alpha为0.78，而项目均匀系数为0.21。几乎所有项目（11/14）达到了可接受的项目 - 总校正相关性（ R. _S. = 0.16–0.50). AS total score was moderately correlated with Beck Depression Inventory (0.34) and with Non-Motor Symptoms Scale domains 2 (sleep/fatigue, 0.35), 3 (mood/apathy, 0.56), and 5 (attention/memory, 0.41). There were no significant differences between AS total scores by established groups of sex, time from diagnosis, HY, and Clinical Global Impression-Severity Scale. Following LCIG treatment, there was no significant change in the AS total score. The relative change was 5.56%, the standard error of the difference was 4.17, and Cohen’s D.效果为0.10。 结论。如表现出令人满意的可行性，可接受性，缩放假设，内部一致性和收敛有效性。响应性参数差，可能是由于这些数据来自的临床研究的特征。此试验已注册 NCT02289729.。SN - 2090-8083 UR - https://doi.org/10.1155/2019/1965394 Do - 10.1155/2019 / 1965394 JF - 帕金森病PB - Hindawi Kw - ER -